We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:RYTM
​
​
logo

Rhythm Pharmaceuticals (RYTM)

Nasdaq • RYTM • US76243J1051

110.68Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 18.7% of free float is sold short, 10.2 days to cover, cost to borrow 0.43%.

Market Cap

7.67b USD | # 2251 in US

Volume

833.38k shares | 83.6m USD

Shares Outstanding

68.85m

Free Float Shares

81.39% | 56.04m

DB:1RV

News

RYTM key data

Rhythm Pharmaceuticals (Nasdaq: RYTM) has a market capitalization of $7.67B. Last close $110.68 (as of 2026-11-05); 52-week range $74.50 to $122.20. ORTEX data as of 2026-11-03: short interest is 18.67% of free float, 10.2 days to cover and the average cost to borrow is 0.43%.

  • RYTM news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.